References

Andrae B, Andersson T M-L, Lambert PC et al. (2012). Screening and cervical cancer cures: population based cohort study. BMJ  e900. Doi: 10.1136/bmj.e900.

Austin RM, Zhao C (2012). Type 1 and type 2 cervical adenocarcinomas: some cervical cancers are more difficult to prevent with screening. Cytopathology 23:6-12.

Bansal N, Wright JD, Cohen CJ, Herzog TJ (2008). Natural history of established low-grade cervical intraepithelial (CIN1) lesions. Anticancer Res 28:1763-6.

Bray F, Carstensen B, Moller H et al. (2005) Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer epidemiol Biomarkers Prev 14:2191-9.

Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ (2005). Cervical cancer in the Netherlands 1989-1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 113:1005-0.

Carozzi FM, Tomesello ML, Burroni E et al. (2010). Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy. Cancer Epidemiol Biomarkers Prev 19:2389-400.

Castle PE, Schiffman M, Wheeler CM, Solomon D (2009). Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 113:18-25.

Darragh TM, Colgan TJ, Cox JT et al. (2012). The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arc Pathol Lab Med 136:1266-97.

de Sanjose S, Quint WGV, Alemany L et al. (2010) Human papillomvirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional survey. Lancet Oncol 11:1048-56.

Galgano MT, Castle PE, Atkins KA et al. (2010). Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 3:1077-87.

Gustafsson L, Adami HO (1989). Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer 60:132-41.

Herbert A, Anshu, Culora G et al. (2010). Invasive cervical cancer audit: why cancers developed in a high-risk population with an organised screening programme. Br J Obstet Gynaecol 117:736-45.

Holowaty P, Miller AB, Rohan T, To T (1999). Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 91:252-8.

Jaisamrarn U, Castellsague X, Garland SM et al. (2013). Natural history of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLoS One 8:e79260.

Jordan J, Arbyn M, Martin-Hirsch P et al. (2008) European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology. Cytopathology 19:342-54.

Kelloff GJ, Sigman CC (2007). Assessing intraepithelial neoplasia and drug safety in cancer-preventative drug development. Nature Reviews Cancer 7:508-18.

McCredie MR, Sharples KJ, Baranyai J et al. (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial  neoplasia 3: a retrospective cohort study. Lancet Oncol 9:425-34.

Ostör AG (1993). Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol  12:186-92.

Ostör AG, Duncan A, Quinn M, Rome R (2000). Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases. Gynecol Oncol 79:207-10.

Peto J, Gilham C, Fletcher O, Matthews FE (2004). The cervical cancer epidemic that screening has prevented in the UK. Lancet 364:249-56.

Prendiville W (2009). The treatment of CIN: what are the risks? Cytopathology 20:145-53.

Sasieni P, Castanon A, Cuzick J (2009). Screening and adenocarcinoma. Int J Cancer 125:525-9.

Stoler MH, Schiffman M (2001). Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 285:1500-5.

Talaat A, Brinkmann D, Dhundee J et al. (2012).  Risk of significant gynaecological pathology in women with ?glandular neoplasia on cervical cytology.  Cytopathology 23:371-7.

Viczaino AP, Moreno V, Bosch FX (1998). International trends in the incidence of cervical cancer: adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 75:536-45.

WHO (2015). World Health Organisation Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC 2015. Available from www.iarc.fr/en/publications/pdfs-online/pat-gen/bb4/index.php

Woodman CJ, Collins C, Rollason TP et al. (2003). Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia.  Lancet 2003;361:40-3. 

X